LETTERS TO THE EDITOR   

Minerva Medica 2018 October;109(5):403-5

DOI: 10.23736/S0026-4806.18.05564-7

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Triple therapy: worth the risk?

Bernhard WERNLY ¹, Michael LICHTENAUER ¹, Uta C. HOPPE ¹, Alexander LAUTEN ², Eliano P. NAVARESE ^{3, 4, 5}, Christian JUNG ⁶ ✉

¹ Department of Cardiology, Clinic of Internal Medicine II, Paracelsus Medical University of Salzburg, Salzburg, Austria; ² Department of Cardiology, Charité - Universitaetsmedizin Berlin, University Heart Center, German Center for Cardiovascular Research (DZHK), Berlin, Germany; ³ Interventional Cardiology and Cardiovascular Medicine Research, Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Falls Church, VA, USA; ⁴ SIRIO MEDICINE, Research Network, Falls Church, VA, USA; ⁵ Cardiovascular Institute, Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland; ⁶ Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, University of Düsseldorf, Düsseldorf, Germany